Autolus Therapeutics PLC reports results for the quarter ended in December - Earnings Summary

Autolus Therapeutics

10/03/2022 15:10

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted
loss of 51 cents​​ per share for the quarter ended in December.
The mean expectation of eight analysts for the quarter was for a
loss of 46 cents per share.
    * Revenue fell 55.4% to $180.00 thousand from a year ago; 
analysts expected $197.00 thousand. 
    * Autolus Therapeutics PLC's reported EPS for the quarter
was a
loss of 51 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Autolus Therapeutics PLC shares had fallen by 26.0% this
quarter.
    * The company reported a quarterly loss of $41.67 million.
    * Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 10 at 03:10 p.m.  ​All
figures in US dollars unless otherwise stated